The company is a high-end medical device group integrating R&D, production and sales of medical devices. It was founded in 2005 in Zhangjiang Torch Park in Pudong, Shanghai. Since its inception, the company has been committed to providing high-quality clinical treatment plans for patients with vertebral compression fractures caused by osteoporosis. Through continuous efforts, Kellitai pioneered the localization of conformist vertebral dilatation balloon catheters in China, filled the domestic gap at the time, broke the technological monopoly of multinational companies, greatly reduced product prices, and benefited the vast majority of domestic patients. The company's main business is the production, R&D, sales and service of orthopedic implantable medical devices. The main products include minimally invasive spinal products, orthopedic trauma implant device products and other corporate honors: China's top 50 pharmaceutical industry growth centers, the company won the annual China Forbes Potential Award in 2017, and the top 50 growth enterprises in the Chinese pharmaceutical industry.
No Data